Vidvan Image

Dr Venkatesan Jayaprakash

vidwan id: 416254
Male

Professor, Department of Pharmaceutical Sciences and Technology
Birla Institute of Technology

Expertise

  • Pharmacology and Pharmacy

Publications

Total Articles 162
Books 0
Proceedings 0

Publications

No publication activity to display at the moment.

Scopus

Citations 2140
h-index 28

CrossRef

CrossRef Icon
Citations 544
h-index 15
Google Scholar

Loading Scholar statistics...

Professional Recognition

2011

WHO's WHO

Marquis
2021

WHO's WHO

Marquis
1996

Junior Research Fellow

UGC, Govt. of India

Community & Membership

2017

Internal Quality Assurance Cell (IQAC), BIT Mesra

Member
2019

Internal Complaint Committee (ICC), BIT Mesra

Member,
2023

Institutional Biosafety Committee (IBSC), BIT Mesra

Member Secretary
2019

Committee for policy formulation on Academic programs, BIT Mesra

Member
2020

Institute Feedback Committee, BIT Mesra

Member
2024

Intellectual Property Rights Cell (IPRC)

Convenor
2024

QIP Centre, Birla Institute of Technology, Mesra

QIP Coordinator
2024

Institution Innovation Council, Birla Institute of Technology, Mesra

Member
2023

Committee for KAPILA

Convenor

Association of Pharmacy Teachers of India

1999
Life Member

Bio

Molecular Modeling and Drug Design and Synthesis of Small Molecule Heterocycles Against Targets of Therapeutical Importance

Personal Details

  • Male
  • Professor , Birla Institute of Technology
  • Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra
Ph.D.
Other Institute 2012
PGDCAQM
Other Institute 2004
m. pharmacy
Other Institute 1999
B. Pharmacy
Other Institute 1996
D. Pharmacy
Other Institute 1992
Professor Aug 2021 – Present
Birla Institute of Technology | Department of Pharmaceutical Sciences and Technology
Associate Professor Jul 2016 – Aug 2021
Birla Institute of Technology | Department of Pharmaceutical Sciences and Technology
Assistant Professor Jun 2007 – Jun 2016
Birla Institute of Technology | Department of Pharmaceutical Sciences and Technology
Lecturer Feb 2004 – May 2007
Birla Institute of Technology | Department of Pharmaceutical Sciences and Technology

Related Profiles

Experts (5849+)

View All
Abhishek

Mr Abhishek Agarwal

Assistant Professor

Preeti

Dr Preeti Sharma

Assistant Professor

Pavithra

Pavithra Velayutham

Assistant Professor

Mahaboob

Dr Mahaboob Basha

Physical Director

HIBA

HIBA -

Assistant Professor

Muskan

Dr Muskan Jain (PT)

Assistant Professor

Shalini

Ms Shalini Saini

Assistant Professor

Organisations (318+)

View All
Brajesh

Mr Brajesh Kumar

Library and Information Assistant

Lakhbir Singh

Dr Lakhbir Singh Brar

Assistant Professor

Baban

Mr Baban Dey

Research Associate

Arun

Dr Arun Mittal

Assistant Professor (Grade-I)

Arup

Dr Arup Choudhury

Associate Professor

Amit Kumar

Dr Amit Kumar Tiwari

Assistant Professor

Atul

Dr Atul Pandey

Assistant Professor

Ashok Kumar

Dr Ashok Kumar Pattnaik

Associate Professor

Arvind

Mr Arvind Sahu

Assistant Librarian

Co-Authors (35)

Arunava

Dr Arunava Dasgupta

Central Drug Research Institute

Abhimanyu

Dr Abhimanyu Dev

Birla Institute of Technology

Amit K

Dr Amit K Das

Indian Institute of Technology Kharagpur

Arindam

Dr Arindam Mondal

Indian Institute of Technology Kharagpur

Ashoke

Dr Ashoke Sharon

Birla Institute of Technology

Ashok Kumar

Dr Ashok Kumar Pattnaik

Birla Institute of Technology

Amit

Dr Amit Singh

Indian Institute of Science Bangalore

Azim Zakir

Mr Azim Zakir Ansari

Shri Vile Parle Kelavani Mandal`s Institute of Pharmacy, Dhule

Sugato

Dr Sugato Banerjee

National Institute of Pharmaceutical Education and Research (NIPER), Kolkata

Biswatrish

Dr Biswatrish Sarkar

Birla Institute of Technology

James

Dr James C

Scott Christian College, Nagercoil

Hari Babu

Prof Hari Babu Bollikolla

Acharya Nagarjuna University

Subhranshu

Dr Subhranshu Panda

Koneru Lakshmaiah Education Foundation, Guntur

D

Dr D Gayathri

University of Madras

Jenepha

Dr Jenepha Mary

Holy Cross College, Nagercoil - 629 004.

Jobin Kunjumon

Mr Jobin Kunjumon Vilapurathu

Nirmala College of Pharmacy, Muvattupuzha - 686 661

Jubie

Dr Jubie Selvaraj

JSS College of Pharmacy, Ooty

Kiran Kumar

Dr Kiran Kumar Pattanaik

ABV Indian Institute of Information Technology & Management, Gwalior

Mahua

Dr Mahua Basu

St. Xavier's College

Abhishake

Dr Abhishake Mondal

Indian Institute of Science Bangalore

Sankaranarayanan

Dr Sankaranarayanan Murugesan

Birla Institute of Technology and Science

Mohd

Dr Mohd Usman MS

Shri Vile Parle Kelavani Mandal`s Institute of Pharmacy, Dhule

Papiya

Dr Papiya Mitra Mazumder

Birla Institute of Technology

Bharathi

Dr Bharathi DR

Adichunchanagiri University

Sahid

Dr Sahid Hussain

Indian Institute of Technology Patna

Sandip Bibishan

Dr Sandip Bibishan Bharate

Indian Institute of Integrative Medicine

Sneha

Dr Sneha Singh

Birla Institute of Technology

Mugada

Dr Mugada Sugunakara Rao

Aditya Institute of Technology & Management, Srikakulam

Rama Rao

Dr Rama Rao Tadikonda

CMR College of pharmacy

Narender

Dr Narender Tadigoppula

Central Drug Research Institute

Vishnu Nayak

Dr Vishnu Nayak Badavath

Narsee Monjee Institute of Management Studies, Mumbai

Scholarly Work

Expanding the scope of anti-cancer drug discovery: A multi-targeted approach for simultaneous inhibition of CDK4, CYP1B1, and tubulin proteins

Funding Agency: ICMR

Principal Investigator

5,418,084

2024 - Ongoing

Ongoing
Aptamer-based diagnostic kit for detection of Corona virus infection (CoVapt)

Funding Agency: SERB

Co-Principal Investigator

1,574,672

2020 - 2021

Completed
Design & development of inhibitors of DENV methyl transferase for the treatment of Dengue viral infection

Funding Agency: AICTE

Principal Investigator

1,738,235

2017 - 2020

Completed
Design and synthesis of substrate based peptide inhibitors of DENV protease for the treatment of Dengue viral infections

Funding Agency: SERB

Co-Principal Investigator

4,560,400

2017 - 2020

Completed
Phenyloxazoline synthetase inhibitiors as antitubercular agents (POSIAA)

Funding Agency: SERB

Principal Investigator

5,373,450

2016 - 2019

Completed
Grid-based virtual screening for TB (Grid-ViSiT)

Funding Agency: AICTE

Co-Principal Investigator

650,000

2008 - 2010

Completed

Design and development of antiviral agents for the treatment of Dengue viral infection 

University Birla Institute of Technology, Mesra
Year 2023

Mycobactin synthesis inhibitors as antitubercular agents

University Birla Institute of Technology, Mesra
Year 2022

Design synthesis and biological evaluation of Cytochrome P450 inhibitors as anticancer agents

University Birla Institute of Technology, Mesra
Year 2019

Design and synthesis of PPAR modulators as possible antidiabetic agents

University Birla Institute of Technology, Mesra
Year 2019

Design synthesis and biological screening of monoamine oxidase inhibitors

University Birla Institute of Technology, Mesra
Year 2018

Design synthesis and screening of small molecule inhibitors against Dengue virus

University Birla Institute of Technology, Mesra
Year 2018

Design and synthesis of antiviral agents for Chikungunya viral infection

University Birla Institute of Technology, Mesra
Year 2017

An aptamer based diagnosis of Covid 19 infection and method thereof

Birla Institute of Technology
Mesra
Medical and Health Sciences Patent No. : 551902 Filed : 28-07-2022
Published : N/A Granted

3-(2-hydroxyphenyl)-5-phenyl-4,5-dihydro-1H-pyrazole derivatives, and method of preparing the same

Birla Institute of Technology
Mesra
Medical and Health Sciences Patent No. : 455777 Filed : 23-12-2021
Published : 03-03-2023 Granted

2-(4,6-diaminopyrimidin-2-ylthio)-N-aryl acetamide derivatives, their synthesis, antiviral activity and methods thereof

Barij Nayan Sinha
Medical and Health Sciences Application No. : 325/KOL/2014 Filed : 17-03-2014
Published : 25-09-2015 Published

4-(1,3-dioxoisoindolin-2-yl)-benzenesulfonamide derivatives, their synthesis, antiviral activity and methods thereof

Barij Nayan Sinha
Medical and Health Sciences Application No. : 191/KOL/2014 Filed : 17-02-2014
Published : 21-08-2015 Published

Arylmethylidene heterocyclics as novel antiviral agents against chikungunya viral infection

Barij Nayan Sinha
Medical and Health Sciences Application No. : 811/KOL/2013 Filed : 08-07-2013
Published : 16-08-2013 Published

Dihydropyrimidine Derivatives as pharmacologically active agents

Synapse Life Sciences
Medical and Health Sciences Application No. : 349/CHE/2011 Filed : 07-02-2011
Published : 25-03-2016 Published

Scholarly Publications

Corrigendum to “A chemical modification of a peroxisome proliferator-activated receptor pan agonist produced a shift to a new dual alpha/gamma partial agonist endowed with mitochondrial pyruvate carrier inhibition and antidiabetic properties” [Eur. J. Med. Chem. 275 (2024) 116567] (European Journal of Medicinal Chemistry (2024) 275, (S0223523424004471), (10.1016/j.ejmech.2024.116567))

Open Access
Erratum
Authors: Laghezza A.;Cerchia C.;Genovese M.;Montanari R.;Capelli D.;Wackerlig J.;Simic S.;Falbo E.;Pecora L.;Leuci R.;Brunetti L.;Piemontese L.;Tortorella P.;Biswas A.;Singh R.P.;Tambe S.;Sudeep C.A.;Pattnaik A.K.;Jayaprakash V.;Paoli P.;Lavecchia A.;Loiodice F.

Identification of novel thiazole derivatives as flaviviral protease inhibitors effective against Dengue (DENV2) and Japanese encephalitis viruses

Open Access
Article
Authors: Murtuja S.;Das S.;Jana I.D.;Shilkar D.;Rakshit G.;Sarkar B.;Sinha B.N.;Dewangan R.P.;Mondal A.;Jayaprakash V.

A chemical modification of a peroxisome proliferator-activated receptor pan agonist produced a shift to a new dual alpha/gamma partial agonist endowed with mitochondrial pyruvate carrier inhibition and antidiabetic properties

Open Access
Article
Authors: Laghezza A.;Cerchia C.;Genovese M.;Montanari R.;Capelli D.;Wackerlig J.;Simic S.;Falbo E.;Pecora L.;Leuci R.;Brunetti L.;Piemontese L.;Tortorella P.;Biswas A.;Singh R.P.;Tambe S.;Sudeep C.A.;Pattnaik A.K.;Jayaprakash V.;Paoli P.;Lavecchia A.;Loiodice F.

Building a ML-based QSAR model for predicting the bioactivity of therapeutically active drug class with imidazole scaffold

Open Access
Article

Prospects for Prostate Cancer Chemotherapy: Cytotoxic Evaluation and Mechanistic Insights of Quinolinequinones with ADME/PK Profile

Open Access
Article
Authors: Ayse Tarbin Jannuzzi;Ayse Mine Yilmaz Goler;Abanish Biswas;Subodh Mondal;Vinay N. Basavanakatti;Hatice Yıldırım;Mahmut Yıldız;Nilüfer Bayrak;Venkatesan Jayaprakash;Amaç Fatih TuYuN

Identification of novel thiazole derivatives as flaviviral protease inhibitors against DENV and JEV

Open Access
preprint
Authors: Sheikh Murtuja;Sayan Das;Indrani Das Jana;Deepak Shilkar;Gourav Rakshit;Biswatrish Sarkar;Barij Nayan Sinha;Rikeshwar Prasad Dewangan;Arindam Mondal;Venkatesan Jayaprakash

Development and validation of HPLC-UV and LC-MS/MS methods for the quantitative determination of a novel aminothiazole in preclinical samples

Open Access
Article
Authors: Basavanakatti V.N.;Ali M.;Bharathi D.R.;Murtuja S.;Sinha B.N.;Jayaprakash V.;Shakeel F.

Machine learning based QSAR model for therapeutically active candidate drugs with thiazolidinedione (TZD) scaffold

Open Access
Article